Ginkgo Bioworks Awarded $9.4 Million Subcontract to Develop Implantable Bioelectronic Devices

MT Newswires Live

2024-12-17

Ginkgo Bioworks (DNA) said Tuesday that it has been awarded a subcontract of up to $9.4 million to develop implantable devices for diagnosing and treating hormone disorders under the Advanced Research Projects Agency for Health's Resilient Extended Automatic Cell Therapies program.

The subcontract is in partnership with Carnegie Mellon University and will focus on bioelectronic cell-based technology, according to the company.

Price: 9.41, Change: -0.02, Percent Change: -0.21

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2492969414"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492969414\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2492969414?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 23:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492969414","market":"nz","top_or_hot":-1,"title":"Ginkgo Bioworks Awarded $9.4 Million Subcontract to Develop Implantable Bioelectronic Devices","media":"MT Newswires Live","content":"<html><body><p> Ginkgo Bioworks (DNA) said Tuesday that it has been awarded a subcontract of up to $9.4 million to develop implantable devices for diagnosing and treating hormone disorders under the Advanced Research Projects Agency for Health's Resilient Extended Automatic Cell Therapies program.</p><p>The subcontract is in partnership with Carnegie Mellon University and will focus on bioelectronic cell-based technology, according to the company.</p><p>Price: 9.41, Change: -0.02, Percent Change: -0.21</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ginkgo Bioworks Awarded $9.4 Million Subcontract to Develop Implantable Bioelectronic Devices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGinkgo Bioworks Awarded $9.4 Million Subcontract to Develop Implantable Bioelectronic Devices\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-12-17 23:19</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Ginkgo Bioworks (DNA) said Tuesday that it has been awarded a subcontract of up to $9.4 million to develop implantable devices for diagnosing and treating hormone disorders under the Advanced Research Projects Agency for Health's Resilient Extended Automatic Cell Therapies program.</p><p>The subcontract is in partnership with Carnegie Mellon University and will focus on bioelectronic cell-based technology, according to the company.</p><p>Price: 9.41, Change: -0.02, Percent Change: -0.21</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DNA.AU","symbol_name":"DONACO INTL LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492969414","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492969414","pubTimestamp":1734448767,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Ginkgo Bioworks  said Tuesday that it has been awarded a subcontract of up to $9.4 million to develop implantable devices for diagnosing and treating hormone disorders under the Advanced Research Projects Agency for Health's Resilient Extended Automatic Cell Therapies program.The subcontract is in partnership with Carnegie Mellon University and will focus on bioelectronic cell-based technology, according to the company.Price: 9.41, Change: -0.02, Percent Change: -0.21","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DNA.AU":"DONACO INTL LTD","BK7078":"赌场与赌博","BK4139":"生物科技","DNA":"Ginkgo Bioworks Holdings Inc.","BK4109":"特种化学制品"},"translate_title":"Ginkgo Bioworks获得价值940万美元的分包合同，开发植入式生物电子设备","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DNA":0.9,"DNA.AU":1},"content_text":"Ginkgo Bioworks (DNA) said Tuesday that it has been awarded a subcontract of up to $9.4 million to develop implantable devices for diagnosing and treating hormone disorders under the Advanced Research Projects Agency for Health's Resilient Extended Automatic Cell Therapies program.The subcontract is in partnership with Carnegie Mellon University and will focus on bioelectronic cell-based technology, according to the company.Price: 9.41, Change: -0.02, Percent Change: -0.21","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}